Page 13 - Trials Network News Today

Sanofi today reports data from two trials, VAT02 Cohort 2 and COVIBOOST VAT013, conducted with its new next-generation COVID-19 booster vaccine candidate modelled on the Beta variant antigen and including GSK’s pandemic adjuvant. In the Phase 3 VAT02 Cohort 2 study, the Sanofi-GSK next-generation vaccine candidate ...

Two Stellenbosch University scientists have been selected for TIME magazine's list of 100 most influential people of 2022.

/PRNewswire/ -- Emmes, a global, full-service clinical research organization (CRO) dedicated to supporting the advancement of public health and...

Monoclonal antibodies and their potential role in combatting COVID-19 - IAVI. Numerous monoclonal antibodies are already in development for both treatment and p

40 years of AIDS vaccine research - IAVI. A timeline of major milestones in the decades-long effort to develop an HIV vaccine.

A step in the right direction - IAVI Report – Vol. 25, No. 1, 2021 - IAVI. Researchers describe the experimental HIV vaccine approach called germline targeting

A new generation of engineered vaccine candidates enters clinical testing - IAVI. Armed with an understanding of HIV’s structure in minute detail and how antibo

An industry leader in HIV research - IAVI. After pursuing medical training in his home country of Belgium, Stoffels began his career as a young physician workin

Taking the next step with the mosaic HIV vaccine candidate - IAVI. IAVI is a nonprofit scientific research organization dedicated to addressing urgent, unmet gl

A tale of two pandemics - IAVI Report – Vol. 25, No. 1, 2021 - IAVI. In conversation with four experts who are applying lessons from the decades-long battle aga